The aim of the study is to determine whether pudendal nerve maximal electrical stimulation (MES) could represent an alternative treatment for detrusor hyperre¯exia in spinal cord injury (SCI) patients. Six suprasacral SCI patients participated in the study. The treatment consisted of daily stimulation periods of 20 min, repeated ®ve times a week, during 4 weeks, with continuous electrical stimulation of the penis or of the clitoris via bipolar surface electrodes (rectangular stimuli of 0.5 ms pulse duration, 5 Hz frequency), with the maximum tolerable stimulation strength (under the level of pain). In two patients, additional stimulation was administrated by means of an anal plug during the last 2 weeks. The stimulus strengths ranged from 35 to 99 mA (mean 54 mA). One patient stopped MES after 2 weeks. At the end of the treatment, neither the cystometric bladder capacities (153 ml vs 157 ml) nor the micturition charts had signi®cantly improved for the ®ve remaining patients. Only two patients experienced non lasting improvement of nocturia at some time of the treatment. In conclusion, we were not able to demonstrate the ecacy of MES in inhibiting detrusor hyperre¯exia in SCI patients. To reach therapeutic eects, other parameters may be needed, such as higher stimulation strengths (currents above or equal to 99 mA) or other currents (such as interferential therapy). Chronic stimulation with external or implanted electrodes using lower currents may represent an alternative.
Introduction
Experimental studies in spinal cord injury (SCI) patients have demonstrated the ecacy of perineal electrical stimulation (ES) in short-term bladder inhibition. 1 ± 4 Studies in the 1970s stated that pudendal nerve maximal electrical stimulation (MES) could induce a profound and long-lasting bladder inhibition in SCI patients. 5 ± 7 These results, essentially based upon clinical observations without statistical validation, were never con®rmed.
The aim of this study is to determine whether pudendal nerve MES could represent an alternative treatment for detrusor hyperre¯exia in SCI patients. In a preliminary study in ten chronic SCI patients, we con®rmed the ecacy of pudendal nerve ES in bladder inhibition. 4 We also stressed the importance of current strength, as this inhibition was only achieved with the highest current strengths (ie twice the bulbocavernosus re¯ex threshold). These results represent the experimental background for the therapeutic use of MES. In this study, the eect of MES on detrusor hyperre¯exia in six chronic suprasacral SCI patients is reported.
Methods
Six chronic suprasacral SCI patients, ®ve males and one woman, were treated by MES ( Table 1 ). The selection of the patients was based on the presence of detrusor hyperre¯exia con®rmed by previous urodynamic studies. They all presented detrusor-sphincter dyssynergia. Re¯ex voiding was the method of bladder emptying in ®ve patients, combined with clean intermittent catheterization (CIC) in four. CIC alone was used in one. All male patients were ®tted with external collecting devices. None of the six patients had any signi®cant urological history. Any medication for bladder dysfunction was stopped at least 72 h before testing. No patient had symptomatic urinary tract infection at the start of the study. They all received prophylactic antibiotic during the stimulation period.
Urodynamic investigations were conducted on entering the study and 4 weeks later. Patients were asked to record micturition frequency, voided volumes and incidental leakage of urine during 48 h periods before the start and throughout MES treatment.
Cystometries were performed as previously described. 4 The water cystometries were done at a ®lling rate of 50 ml/min using a double lumen, transurethral 8F Porges catheter. Perineal electromyography using a concentric needle was also recorded during the cystometry, but rectal and urethral pressures were not systematically measured. The ®lling was stopped at the onset of an uninhibited bladder contraction of more than 15 cm H 2 O.
The treatment consisted of daily stimulation periods of 20 min, repeated ®ve times a week, during 4 weeks. MES was applied to the dorsal penile nerve with Velcro ribbon electrodes (Dantec) and to the dorsal nerve of the clitoris with a bipolar surface disc electrode (Dantec). A continuous biphasic current with repetitive stimulation (5 Hz) and rectangular stimuli (0.5 ms duration) was conducted with a Dantec Contrepoint EMG system. The individual maximal tolerable stimulation strength was chosen by slowly increasing the current intensity (with a maximum of 99 mA delivered by the stimulation device), and readjusted on a daily basis. Additional ES by means of an anal plug was performed in two patients (JV, TS) for the last 2 weeks of treatment. In these cases, pudendal and anal ES increased in parallel.
Discontinuous, non invasive cardiovascular monitoring was performed during the cystometries and the stimulation periods. All subjects were fully informed about the experimental procedures and gave their informed consent. They all volunteered for this protocol approved by the local ethical committee. Cystometric data (bladder capacity) were analyzed with a Wilcoxon test using paired data. A signi®cance level of 0.05 was adopted. Changes in the micturition charts were analyzed on a case by case basis. Table 2 shows the results of the study. The current amplitudes varied widely between patients, but were relatively constant for each patient during the 20 sessions. Stimulation strengths ranged from 35 to 99 mA (mean 54.0 mA). Pelvic¯oor muscle contractions were seen in all. One patient (DC, tetraplegia, ASIA Impairment Scale B) dropped out of the study after 15 days due to a prostatitis. In this case, we only analyzed the micturition chart for the 10 ®rst days of treatment.
Results
For the ®ve remaining patients, the stimulation strengths ranged from 35 to 65 mA (mean 41.0 mA). There were no statistical dierences between the mean cystometric bladder capacity values before and after treatment (153 ml and 157 ml, respectively). The analysis of the micturition charts did not reveal any improvement in micturition frequency or voided volumes in any patients. Only two patients (GS, TS) experienced non-lasting improvement of nocturia at some time of the stimulation period.
The MES was well tolerated in all patients. The individual maximum tolerable stimulus was occasionally described as unpleasant, but never as painful. No changes in blood pressure or pulse rate were noted during the stimulation periods.
Discussion
In non-neuropathic bladder dysfunction, experimental and clinical studies have shown that maximal electrical stimulation (MES) induces pronounced and lasting bladder inhibition. 8 Limited experience exists in its use in the treatment of neuropathic bladder dysfunction (Table 3) . 5,6,9 ± 11 Former studies stated that MES resulted in an improvement of detrusor hyperre¯exia in SCI patients. 5 ± 7 From our clinical and cystometric evaluations, we were not able to demonstrate the ecacy of MES in inhibiting detrusor hyperre¯exia in SCI patients.
Micturition chart recordings and cystometric bladder capacity evaluations were chosen to record 12 but may not be the most appropriate instrument to record changes in an overactive bladder. 9, 13 On the other hand, the micturition chart, that re¯ects better the normal life conditions, provides more valuable information. 9 Electrical parameters used in this study were in line with general recommendations to achieve bladder inhibition. They were discussed in our preliminary paper. 4 Most authors feel that the strongest electrical stimulation (ES) has the highest probability to be ecient. 8, 13 In the uninhibited overactive bladder, Ohlsson et al found a clear correlation between the current intensity and the clinical result. 9 In this study, the current amplitudes were adjusted just below the pain threshold, but varied widely between patients ( Table 2 ). The relatively low mean intensities found in our patients are a possible explanation for the failure of the treatment. Additional anal ES was applied in two patients, so that this low intensity could be compensated for by a higher degree of aerent pudendal nerve activation, 14 but this failed to induce any change. If higher intensities are needed to reach a therapeutic eect, a selection of patients should be made, as this MES could only be tolerated by few SCI patients, mainly by patients with a complete lesion (ASIA Impairment Scale A).
The frequency of ES is another parameter to consider. Low-frequency stimulation of 5 Hz is optimal for bladder inhibition whereas high-frequency stimulation of 50 Hz is optimal to achieve the urethral closure. 8 The low frequency of 5 Hz is unpleasant. Subjects are able to discriminate each single pulse. In further studies in complete or incomplete SCI patients, the use of a better tolerated 10 to 20 Hz frequency ES seems a reasonable compromise between optimal bladder inhibition and patient tolerance. 8 Petersen et al failed to show any evidence of acute or chronic bladder inhibition by sphincter stimulation in multiple sclerosis patients. 10 Table 3 shows dierences in other electrical parameters. However, the advantage of monophasic vs biphasic or continuous vs alternating currents has not yet been demonstrated. Dierent stimulation sites can be used, but ES of nonmuscular somatic aerent branches of the pudendal nerve (dorsal penile nerve and dorsal nerve of the clitoris) could provide a more speci®c bladder inhibition than other available techniques. 2, 3 The relatively short interval between spinal cord injury and electrical stimulation (Table 2) could raise the question as to the progress of the neuropathic voiding dysfunctions. However, the follow-up cystometries performed later revealed that the patients were all stabilised at the time of the study. The discussion on the possible mechanisms of action can be found in our preliminary paper. 4 In conclusion, we were not able to demonstrate the ecacy of pudendal nerve MES in inhibiting detrusor hyperre¯exia in SCI patients. To reach therapeutic eects, currents above or equal to 99 mA may be needed. If so, MES treatment will only be applicable to a few patients. Other types of currents, such as interferential therapy used in multiple sclerosis patients, 15 are worth trying. Chronic ES with external or implanted electrodes using lower currents may represent an alternative. 16, 17 Acknowledgements This work was supported by a grant from the INSERM (921106). 
